WASHINGTON, May 22, 2018 /PRNewswire-USNewswire/ -- Wounded Warrior Project® (WWP) is pleased and supportive of the president's nomination of Robert Wilkie to become the next Secretary of Veterans Affairs (VA). In his tenure as Acting Secretary, Wilkie has demonstrated tremendous ability to lead and focus on the issues of highest concern in the veteran community.
"Before the Senate even begins his confirmation process, Mr. Wilkie will have already placed VA on a path to modernizing its health records and helped bring Congress to the precipice of passing groundbreaking expansions to community care and caregiver assistance programs," said René Bardorf, WWP senior vice president of government and community relations. "We look forward to continuing to work alongside VA leadership to help deliver on our mission to honor and empower Wounded Warriors, and we are confident Mr. Wilkie will continue to demonstrate the experience, skills, and passion to become the transformative leader our veterans deserve."
About Wounded Warrior Project Since 2003, Wounded Warrior Project® (WWP) has been meeting the growing needs of warriors, their families, and caregivers ? helping them achieve their highest ambition. Learn more: http://newsroom.woundedwarriorproject.org/about-us.
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
